UNSPSC 51451805: Albendazole oxide

This classification denotes an antihelminthic agent with the molecular formula C12H15N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J39B52TV34, chemically known as carbamic acid, (5-propylsulfinyl)-1h-benzimidazol-2-yl)-, methyl ester but more generally known as albendazole oxide, which bears US NIH Compound Identifier 83969. European Medicines Agency schedules Albendazole oxide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05296MIG.

UNSPSC 51451805 Albendazole oxide is a Commodity code representing a specific pharmaceutical active ingredient; however, the recent state and local opportunities tagged under this code show little relevance to albendazole oxide itself. The Illinois Department of Public Health's August 28, 2026 piggyback contract through MMCAP Infuse (awarded to Chartwell Rx LLC for $2,999,999.11 over three years) supplied Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets, while Seminole County, Florida's June 30, 2026 IFB sought Naloxone and Safe Drug Deactivation Systems on an annual basis. None of these products correspond to albendazole oxide, an antiparasitic agent, suggesting either a tagging error in the source data or that state and local procurement offices are not currently soliciting this specific ingredient through these visible channels.

The code shows activity primarily in Florida and Illinois, with no additional geographic concentration evident in the available records. Recent opportunities are driven by county health departments and state health agencies seeking emergency pharmaceuticals and public health supplies through cooperative purchasing vehicles and competitive bidding. Without current solicitations specifically for albendazole oxide, prospective vendors should monitor state pharmaceutical procurement portals and health department RFQs directly rather than rely on this code as a reliable signal for relevant opportunities.